close

Fenwick Represents Amyris in its $50M At Market Issuance Sales Agreement

April 12, 2016

​​Fenwick & West LLP represented Amyris (NASDAQ: AMRS), a leading integrated industrial biotechnology company, in its entry into a $50 million At Market Issuance Sales Agreement with FBR Capital Markets & Co. and MLV & Co. LLC as Agents.

The Fenwick transaction team included corporate partner Daniel Winnike and corporate associates Faisal Rashid, Priscila Bastazin, Ryan McRobert and Travis Robertson.